Combiwave SF 25 mcg/250 mcg Inhaler
By Combiwave SF
Rx
150mdi Inhaler in a Packet

Composition
Salmeterol(25mcg) + Fluticasone Propionate(250mcg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
August, 2025

liver
When it comes to the safety of your liver while using Combiwave SF 25 mcg/250 mcg Inhaler, there have been no known interactions or issues identified. It is important to bear in mind that no caution or safety advice specific to liver concerns has been established. However, it is always recommended to consult with your doctor for proper guidance before using Combiwave SF 25 mcg/250 mcg Inhaler to ensure the best and safest outcome for your health.

kidney
No interaction found with Combiwave SF 25 mcg/250 mcg Inhaler and kidney issues. No specific safety advice related to kidney concerns. Consult with your doctor for proper guidance before using Combiwave SF 25 mcg/250 mcg Inhaler.

alcohol
Safety advice regarding alcohol consumption with Combiwave SF 25 mcg/250 mcg Inhaler is unavailable. Please consult your doctor for further guidance.

driving
When using Combiwave SF 25 mcg/250 mcg Inhaler, no interactions with driving have been found or established. It is important to be cautious while driving and always follow safe driving practices.

pregnancy
Combiwave SF 25 mcg/250 mcg Inhaler may not be safe to use during pregnancy. Animal studies show potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before using.

breastfeeding
It is better to consult your doctor before using Combiwave SF 25 mcg/250 mcg Inhaler during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹423
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024